| [1] |
Boeckh M, Geballe AP. Cytomegalovirus: pathogen, paradigm, and puzzle[J]. J Clin Invest,2011,121(5):1673-1680.
|
| [2] |
Tomtishen JP, 3rd. Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28)[J]. Virol J,2012,9(1):1-9.
|
| [3] |
Fortunato EA, Dell’Aquila ML, Spector DH. Specific chromosome 1 breaks induced by human cytomegalovirus[J]. Proc Natl Acad Sci USA,2000,97(2):853-858.
|
| [4] |
赵杨, 闻良珍. 妊娠期人巨细胞病毒感染的研究现况[J]. 中华围产医学杂志,2004,7(2):121-122.
|
| [5] |
Maidji E, Percivalle E, Gerna G, et al. Transmission of human cytomegalovirus from infected uterine microvascular endothelial cells to differentiating/invasive placental cytotrophoblasts[J]. Virology,2002,304(1):53-69.
|
| [6] |
Korndewal MJ, Mollema L, Tcherniaeva I, et al. Cytomegalovirus infection in the Netherlands: seroprevalence, risk factors, and implications[J]. J Clin Virol,2015,63:53-58.
|
| [7] |
Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection[J]. Rev Med Virol,2010,20(4):202-213.
|
| [8] |
Yan XC, Wang JH, Wang B, et al. Study of human cytomegalovirus replication in body fluids, placental infection, and miscarriage during the first trimester of pregnancy[J]. J Med Virol,2015,87(6):1046-1053.
|
| [9] |
王芳, 马骏, 李芬. 人巨细胞病毒宫内感染的研究进展[J]. 现代妇产科进展,2005,14(1):56-58.
|
| [10] |
北京地区母婴巨细胞病毒感染课题组. 北京地区新生儿先天巨细胞病毒感染状况研究[J]. 中国新生儿科杂志,2012,27(1):5-9.
|
| [11] |
Enders G, Daiminger A, Bader U, et al. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age[J]. J Clin Virol,2011,52(3):244-246.
|
| [12] |
Davis NL, King CC, Kourtis AP. Cytomegalovirus infection in pregnancy[J]. Birth Defects Res,2017,109(5):336-346.
|
| [13] |
Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy[J]. Lancet Infect Dis,2017,17(6):e177-e188.
|
| [14] |
Malcolmson C, Ng K, Hughes S, et al. Impact of matrix-assisted laser desorption and ionization time-of-flight and antimicrobial stewardship intervention on treatment of bloodstream infections in hospitalized children[J]. J Pediatric Infect Dis Soc,2017,6(2):178-186.
|
| [15] |
郭丽丽, 许红梅. 人巨细胞病毒感染的流行病学研究进展[J]. 山东医药,2017,31(12):1131-1133.
|
| [16] |
姜毅. 先天性巨细胞病毒感染母婴传播及诊断[J]. 中国新生儿科杂志,2009,24(5):261-265.
|
| [17] |
Guerra B, Lazzarotto T, Quarta S, et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection[J]. Am J Obstet Gynecol,2000,183(2):476-482.
|
| [18] |
姚丽, 张梅, 郭先成. 孕妇巨细胞病毒感染载量与胎儿宫内感染的相关性分析[J]. 中华医院感染学杂志,2015,(15):3550-3552.
|
| [19] |
张立群, 巩振华, 李毅. 孕中期巨细胞病毒宫内感染的临床研究[J/CD]. 世界最新医学信息文摘(连续型电子期刊),2015,15(3):76-78.
|
| [20] |
李淑涓, 曹云. 早产儿经母乳获得性巨细胞病毒感染的研究进展[J]. 中华围产医学杂志,2014,17(11):773-777.
|
| [21] |
Lanzieri TM, Dollard SC, Josephson CD, et al. Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants[J]. Pediatrics,2013,131(6):e1937-e1945.
|
| [22] |
Dioverti MV, Razonable RR. Cytomegalovirus[J]. Microbiol Spectr,2016,4(4):97-125
|
| [23] |
Society for Maternal-Fetal Medicine (SMFM), Hughes BL, Gyamfi-Bannerman C. Diagnosis and antenatal management of congenital cytomegalovirus infection[J]. Am J Obstet Gynecol,2016,214(6):B5-B11.
|
| [24] |
Marsico C, Kimberlin DW. Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment[J]. Ital J Pediatr,2017,43(1):38.
|
| [25] |
桑洪爱, 王琳琳, 刘振平, 等. 孕妇巨细胞病毒感染对胎儿及新生儿的影响[J/CD]. 中国产前诊断杂志(电子版),2015(1):36-39.
|
| [26] |
王晓红. 婴儿巨细胞病毒感染与胆道闭锁的关系[J]. 实用儿科临床杂志,2005,3(20):274-275.
|
| [27] |
左江成, 曾一芹, 向希映, 等. 母乳期婴儿巨细胞病毒感染现状与传播途径分析[J]. 实用医学杂志,2015,31(1):140-143.
|
| [28] |
Hayden RT, Yan X, Wick MT, et al. Factors contributing to variability of quantitative viral PCR results in proficiency testing samples: a multivariate analysis[J]. J Clin Microbiol,2012,50(2):337-345.
|
| [29] |
Gleaves CA, Smith TF, Shuster EA, et al. Comparison of standard tube and shell vial cell culture techniques for the detection of cytomegalovirus in clinical specimens[J]. J Clin Microbiol,1985,21(2):217-221.
|
| [30] |
赵缜, 李敏, 彭奕冰, 等. 人巨细胞病毒pp65抗原血症检测方法的建立和初步临床应用[J]. 检验医学,2004,19(1):36-39.
|
| [31] |
Razonable RR, Paya CV, Smith TF. Role of the laboratory in diagnosis and management of cytomegalovirus infection in hematopoietic stem cell and solid-organ transplant recipients[J]. J Clin Microbiol,2002,40(3):746-752.
|
| [32] |
St George K, Rinaldo CR, Jr. Comparison of cytomegalovirus antigenemia and culture assays in patients on and off antiviral therapy[J]. J Med Virol,1999,59(1):91-97.
|
| [33] |
Pass RF, Zhang C, Evans A, et al. Vaccine prevention of maternal cytomegalovirus infection[J]. N Engl J Med,2009,360(12):1191-1199.
|
| [34] |
Nigro G, Adler SP, La Torre R, et al. Congenital Cytomegalovirus Collaborating Group: Passive immunization during pregnancy for congenital cytomegalovirus infection[J]. N Engl J Med,2005,353(13):1350-1362.
|
| [35] |
Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus[J]. N Engl J Med,2014,370(14):1316-1326.
|
| [36] |
Buxmann H, Stackelberg OM, Schlosser RL, et al. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis[J]. J Perinat Med,2012,40(4):439-446.
|
| [37] |
Nigro G, Capretti I, Manganello AM, et al. Primary maternal cytomegalovirus infections during pregnancy: association of CMV hyperimmune globulin with gestational age at birth and birth weight[J]. J Matern Fetal Neonatal Med,2015,28(2):168-171.
|
| [38] |
Jacquemard F, Yamamoto M, Costa JM, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection[J]. Bjog,2007,114(9):1113-1121.
|
| [39] |
Visentin S, Manara R, Milanese L, et al. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age[J]. Clin Infect Dis,2012,55(4):497-503.
|
| [40] |
Lowance D, Neumayer HH, Legendre CM, et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group[J]. N Engl J Med,1999,340(19):1462-1470.
|
| [41] |
Hou B, Zhang Y. Risk of birth defects after use of acyclovir, valacyclovir, and famciclovir in the first trimester[J]. JAMA,2010,304(20):2242-2243.
|
| [42] |
Leruez-Ville M, Ghout I, Bussieres L, et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase Ⅱ study[J]. Am J Obstet Gynecol,2016,215(4):462.e461-462. e410.
|
| [43] |
Whitley RJ, Cloud G, Gruber W, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase Ⅱ study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group[J]. J Infect Dis,1997,175(5):1080-1086.
|
| [44] |
Kimberlin DW, Lin CY, Sanchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial[J]. J Pediatr,2003,143(1):16-25.
|
| [45] |
Kimberlin DW, Jester PM, Sanchez PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease[J]. N Engl J Med,2015,372(10):933-943.
|
| [46] |
Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus[J]. N Engl J Med,2014,370(14):1316-1326.
|
| [47] |
Funaro A, Gribaudo G, Luganini A, et al. Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells[J]. BMC Biotechnol,2008,8(1):85.
|